Recursion Pharmaceuticals Announced The Pricing Of Its Underwritten Public Offering Of 30,769,230 Shares Of Its Class A Common Stock At A Price To The Public Of $6.50 Per Share
Portfolio Pulse from Benzinga Newsdesk
Recursion Pharmaceuticals announced the pricing of its underwritten public offering of 30,769,230 shares of its Class A common stock at $6.50 per share.
June 27, 2024 | 7:10 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Recursion Pharmaceuticals announced the pricing of its underwritten public offering of 30,769,230 shares of its Class A common stock at $6.50 per share.
The announcement of a public offering typically leads to a short-term decrease in stock price due to dilution of existing shares. The offering price of $6.50 per share may also set a new reference point for the stock's value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100